Literature DB >> 3594908

Relationship between albumin and fructosamine concentration in diabetic and non-diabetic sera.

R N Johnson, P A Metcalf, J R Baker.   

Abstract

We investigated the contribution of albumin to serum fructosamine activity. On gel exclusion chromatography, pooled diabetic and pooled non-diabetic sera before and after incubation with [14C]glucose differed in fructosamine activity and radioactivity mainly in the albumin-containing fractions. We confirmed the major contribution of glycated albumin to serum fructosamine concentration using affinity chromatography on Blue Sepharose. The importance of high molecular mass species was further demonstrated by the recovery of reducing activity following dialysis and charcoal treatment. Fructosamine measurements in diabetic patients were not correlated with serum albumin concentration in individuals with urinary albumin less than 1 g/l. We conclude that fructosamine activity is a convenient measure of glycosylprotein concentration and that the index responds mainly to glycation of albumin. However, routine correction for serum albumin concentration is inappropriate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594908     DOI: 10.1016/0009-8981(87)90066-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  An evaluation of serum fructosamine as a marker of the duration of hypoproteinaemic conditions in dogs.

Authors:  S I Thoresen; W P Bredal
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

2.  Study of the effect of total serum protein and albumin concentrations on canine fructosamine concentration.

Authors:  A Loste; M C Marca
Journal:  Can J Vet Res       Date:  1999-04       Impact factor: 1.310

Review 3.  Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.

Authors:  James Ling; Jack K C Ng; Juliana C N Chan; Elaine Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

4.  The clinical usefulness of serum fructosamine and HbAlc in patients with NIDDM.

Authors:  S Y Lim; Y M Jhoo; S S Lee; M H Lee; E S Chung; S J Lee
Journal:  Korean J Intern Med       Date:  1989-07       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.